A few more serious side effects, like pancreatitis and thyroid C-cell tumors, did appear in some trials, but more testing is needed
[11] Drug interactions listed on the package insert include delayed or reduced concentrations of lovastatin, paracetamol (acetaminophen), and digoxin, although this has not been proven to alter the effectiveness of these other medications
But in March 2024, after clinical trial results published in November 2023 showed that semaglutide-based GLP-1s such as Novo Nordisks Wegovy can reduce cardiovascular incidents, Medicare announced that Part D plans could cover Wegovy for patients with an elevated body mass index (BMI) and established cardiovascular disease. Medicare has yet to provide an exact definition of established cardiovascular disease, so its unclear how many beneficiaries would qualify for the coverage
GLP-1 headaches are common during the adjustment period
Thyroid issues Your thyroid gland is another area involved in body temperature
Because then if we go back to the businesses, those two large e-com- Thimu and Sheen
